Effectiveness of Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients in the United States - PubMed
3 hours ago
- #real-world effectiveness
- #solid organ transplant
- #RSV vaccination
- RSV vaccination in solid organ transplant recipients (SOTRs) aged ≥60 years is associated with a reduced risk of RSV infection (HR 0.70, 95% CI 0.56-0.88).
- Vaccinated SOTRs had lower risks of RSV-related hospitalization (HR 0.61, 95% CI 0.43-0.86) and all-cause mortality (HR 0.45, 95% CI 0.41-0.50).
- The study found no significant association between vaccination and reduced risks of ICU admission or intubation due to RSV.
- Results were consistent across sensitivity and subgroup analyses, supporting vaccination for SOTRs to lower morbidity and mortality.